226 related articles for article (PubMed ID: 23139272)
1. Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association.
Bhattacharya S; Chaum E; Johnson DA; Johnson LR
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8350-66. PubMed ID: 23139272
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Mdm2 sensitizes human retinal pigment epithelial cells to apoptosis.
Bhattacharya S; Ray RM; Chaum E; Johnson DA; Johnson LR
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3368-80. PubMed ID: 21345989
[TBL] [Abstract][Full Text] [Related]
3. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
4. Age-related distribution and potential role of SNCB in topographically different retinal areas of the common marmoset Callithrix jacchus, including the macula.
Hadrian K; Melkonyan H; Schlatt S; Wistuba J; Wasmuth S; Heiligenhaus A; Thanos S; Böhm MRR
Exp Eye Res; 2019 Aug; 185():107676. PubMed ID: 31128101
[TBL] [Abstract][Full Text] [Related]
5. Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).
Drakos E; Singh RR; Rassidakis GZ; Schlette E; Li J; Claret FX; Ford RJ; Vega F; Medeiros LJ
Leukemia; 2011 May; 25(5):856-67. PubMed ID: 21394100
[TBL] [Abstract][Full Text] [Related]
6. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.
Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT
Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway.
Suzuki T; Yamashita C; Zemans RL; Briones N; Van Linden A; Downey GP
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):742-55. PubMed ID: 19307610
[TBL] [Abstract][Full Text] [Related]
8. MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity.
Saha MN; Jiang H; Jayakar J; Reece D; Branch DR; Chang H
Cancer Biol Ther; 2010 Jun; 9(11):936-44. PubMed ID: 20418664
[TBL] [Abstract][Full Text] [Related]
9. CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability.
Huart AS; MacLaine NJ; Meek DW; Hupp TR
J Biol Chem; 2009 Nov; 284(47):32384-94. PubMed ID: 19759023
[TBL] [Abstract][Full Text] [Related]
10. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
11. MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63.
Gamble LD; Kees UR; Tweddle DA; Lunec J
Oncogene; 2012 Feb; 31(6):752-63. PubMed ID: 21725357
[TBL] [Abstract][Full Text] [Related]
12. IL-6-induced acetylation of E2F1 aggravates oxidative damage of retinal pigment epithelial cell line.
Gong C; Qiao L; Feng R; Xu Q; Zhang Y; Fang Z; Shen J; Li S
Exp Eye Res; 2020 Nov; 200():108219. PubMed ID: 32910941
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation induces a p53-dependent apoptotic mechanism in ARPE-19 cells.
Jiang YL; Escaño MF; Sasaki R; Fujii S; Kusuhara S; Matsumoto A; Sugimura K; Negi A
Jpn J Ophthalmol; 2004; 48(2):106-14. PubMed ID: 15064971
[TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL induces apoptosis of human retinal pigment epithelium through activation of ERK-Bax/Bcl-2 signaling pathways.
Yating Q; Yuan Y; Wei Z; Qing G; Xingwei W; Qiu Q; Lili Y
Curr Eye Res; 2015 Apr; 40(4):415-22. PubMed ID: 24956392
[TBL] [Abstract][Full Text] [Related]
15. Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
Zheng T; Wang J; Song X; Meng X; Pan S; Jiang H; Liu L
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1597-604. PubMed ID: 20174822
[TBL] [Abstract][Full Text] [Related]
16. Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells.
Lin H; Qian J; Castillo AC; Long B; Keyes KT; Chen G; Ye Y
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6308-14. PubMed ID: 21693609
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression.
Palani CD; Beck JF; Sonnemann J
Invest New Drugs; 2012 Feb; 30(1):25-36. PubMed ID: 20680659
[TBL] [Abstract][Full Text] [Related]
18. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells.
Elison JR; Cobrinik D; Claros N; Abramson DH; Lee TC
Arch Ophthalmol; 2006 Sep; 124(9):1269-75. PubMed ID: 16966622
[TBL] [Abstract][Full Text] [Related]
19. Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation.
Park EJ; Choi KS; Yoo YH; Kwon TK
Anticancer Drugs; 2013 Mar; 24(3):260-9. PubMed ID: 23187459
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
Saha MN; Jiang H; Chang H
Cancer Biol Ther; 2010 Sep; 10(6):567-78. PubMed ID: 20595817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
